Latest Lou Gehrig Stories
America's brave men and women in uniform are more likely to die from ALS than any other segment of the U.S. population WASHINGTON, May 23, 2013 /PRNewswire-USNewswire/ -- The ALS Association joins the nation this Memorial Day to remember all of the men and women who died while serving in the U.S. military. During May, ALS Awareness Month, The ALS Association is also paying tribute to veterans like retired Air Force Technical Sergeant David Masters of Omaha, Nebraska, who fought...
CAMBRIDGE, Mass., May 14, 2013 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced today that 38 microbrewers across the country have joined the Ales for ALS campaign in support of ALS TDI's mission to discover and develop effective treatments for ALS, commonly known as Lou Gehrig's disease. Ales for ALS(TM) is a unique craft brewery-based fundraising initiative created to accelerate drug development for ALS patients today. (Logo:...
WASHINGTON, May 6, 2013 /PRNewswire-USNewswire/ -- BAYADA Home Health Care is now a national partner of The ALS Association and a Walk to Defeat ALS® Gold National Team. The suburban Philadelphia, Pa.- based company, which provides nursing, rehabilitative, therapeutic, hospice, and assistive care services to children, adults, and seniors in the comfort of their homes, has joined forces with the national non-profit to raise awareness of amyotrophic lateral sclerosis (ALS), otherwise...
LEXINGTON, Mass., April 24, 2013 /PRNewswire-USNewswire/ -- The ninth annual "The Cure is Coming!" 5k and awareness walk to end ALS will be held on Saturday, May 4, 2013 in Lexington, MA. The event will gather local area residents to run, walk, or roll to raise money and awareness for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. All proceeds will benefit research efforts at the Cambridge, MA-based nonprofit biotech, the ALS Therapy Development Institute...
CAMBRIDGE, Mass., April 23, 2013 /PRNewswire-USNewswire/ -- In recognition of people under 30 years old affected by amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, the ALS Therapy Development Institute (ALS TDI) announced today that it has appointed representatives to lead the Young Faces of ALS (YFALS) campaign this year. (Logo: http://photos.prnewswire.com/prnh/20110204/DC42625LOGO) The YFALS program is driven by several ALS patients diagnosed with the...
WASHINGTON, April 3, 2013 /PRNewswire-USNewswire/ -- April is National Volunteer Month, and The ALS Association is recognizing the important role volunteers play in the lives of people living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease. ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. The disease robs people of the ability to walk, to talk and even blink an eye. It traps them inside a body...
Rockefeller Plaza Exhibit Highlights Hope for the Growing Health Concern NEW YORK, April 2, 2013 /PRNewswire/ -- As the leader for research in ALS, the devastating brain disorder also known as Lou Gehrig's disease, Project A.L.S. has been selected by EHE International to raise awareness about ALS and related brain diseases in a 103-square foot window display in Rockefeller Plaza. The interactive Project A.L.S. exhibit debuts today in the major international thoroughfare, and will be...
WASHINGTON, April 2, 2013 /PRNewswire-USNewswire/ -- In work supported by The ALS Association and funded through its Milton Safenowitz Post-Doctoral Fellowship Program, researchers in Baltimore, Md., have shown that cells that normally support neurons in the spinal cord instead worsen the disease in an animal model of amyotrophic lateral sclerosis (ALS). The study was published in the journal Nature Neuroscience on March 31. ALS, also known as Lou Gehrig's Disease, is a progressive...
WASHINGTON, March 29, 2013 /PRNewswire-USNewswire/ -- The injection of antisense molecules into the space around the spinal cord of people with ALS is safe according to research published today. The first-in-human trial of this new therapy was funded by The ALS Association. The study was published today in the scientific journal Lancet Neurology. ALS, also known as Lou Gehrig's Disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal...
WASHINGTON, March 14, 2013 /PRNewswire-USNewswire/ -- In research supported by The ALS Association and published in the online journal Neuron, scientists in London have shown that mutation in a gene that causes amyotrophic lateral sclerosis (ALS) reduces the energy supply in neurons and other cells--suggesting that the inability to produce sufficient quantities of energy is an important step in causing some cases of ALS. ALS, also known as Lou Gehrig's Disease, is a progressive...
